Adaptation and Implementation of a Patient Navigation Program for Cervical Cancer Screening Across Contexts in Senegal
Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Sep 14, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving cervical cancer screening in Senegal to help prevent unnecessary deaths. Researchers are working to understand and overcome the barriers that women face when trying to get screened and treated for cervical cancer. They will be testing a patient navigation program, which is designed to guide women through the process of getting screened and treated, especially in urban and rural areas. By studying how this program can be adapted to different community needs, the team aims to gather valuable insights that can enhance cervical cancer prevention efforts in Senegal and similar countries.
To be eligible for this study, participants must be Senegalese citizens aged between 25 and 69 and willing to take part in surveys. The study will include both men and women, especially those who are directly involved in healthcare or live with someone who is eligible for cervical cancer services. If you decide to participate, you can expect to share your experiences and opinions, which will help improve healthcare services for cervical cancer in your community. This trial is currently recruiting participants, and it aims to create lasting improvements in how cervical cancer is addressed in Senegal.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- The inclusion criteria for samples a, b, \& c are as follows:
- • 1) Senegal citizen between the ages of 25 and 69, 2) willing to participate in survey assessments;
- The additional criteria apply for both women and men for the follow samples:
- • Sample a: 3) an invited member of the study National Advisory Board or Regional Implementation Resource Teams as defined above; 4) able to read and write in French.
- • Sample b: 3) employed by the state at a study site health facility as a patient navigator, clinician (nurse, midwife) who treats and educates patients, or is a community health worker at the facility or community level (Bajenu Gox - women's health educator).
- • Sample c: Women: 3) a woman living with a male partner who also agrees to participate in the study, 4) eligible to seek cervical cancer prevention services at a designated health facility in Senegal. Men: 3) a man living in a household with at least one woman eligible to seek cervical cancer prevention services at a designated health facility in Senegal.
- Exclusion Criteria:
- • No additional exclusion criteria exist.
About University Of Illinois At Chicago
The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dakar, , Senegal
Patients applied
Trial Officials
Jon A Dykens, MD, MPH
Principal Investigator
University of Illinois at Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials